These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6072684)

  • 1. [Experiences with intrathecal corticosteroid treatment of polysclerosis and other neurological diseases].
    Schmidt E
    Psychiatr Neurol Med Psychol (Leipz); 1967 Apr; 19(4):152-6. PubMed ID: 6072684
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with intrathecal glucocorticoid therapy in inflammatory neurological diseases (35 case reports)].
    Göpel W; Bertram W
    Z Arztl Fortbild (Jena); 1971 Jan; 65(2):99-103. PubMed ID: 5109213
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathogenetic therapy of nervous system and muscular diseases using large doses of prednisolone on alternate days].
    Gekht BM; Kuzin MI; Kolomenskaia EA; Gnezditskaia EV; Zefirova GS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):286-90. PubMed ID: 220823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
    Steinbrecher W
    Med Welt; 1969 Nov; 48():2636-49. PubMed ID: 4318400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Meningitis after intrathecal administration of corticosteroids].
    Schock G; Wieczorek V
    Psychiatr Neurol Med Psychol (Leipz); 1974 Aug; 26(8):477-9. PubMed ID: 4480094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endogenous cortisol levels after intrathecal injection of triamicinolone acetonide in patients with neurological disease (author's transl)].
    Neu I; Reusche E; Rodiek S
    Dtsch Med Wochenschr; 1978 Sep; 103(35):1368-70. PubMed ID: 581070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Steroid therapy for neurologic diseases--indications and methods of administration].
    Takatsu M; Toyokura Y
    Nihon Rinsho; 1979 Jun; 37(6):1308-15. PubMed ID: 225590
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results].
    Hanák L; Zouhar A
    Cesk Neurol Neurochir; 1974 Sep; 37(5):287-92. PubMed ID: 4479028
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal methylprednisolone for multiple sclerosis: evaluation by a standard neurological rating.
    Baker AG
    Ann Allergy; 1967 Dec; 25(12):665-72. PubMed ID: 6072742
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment].
    Jedlicka P; Kupka J; Kocinová F
    Cesk Neurol Neurochir; 1975 Dec; 38(6):338-45. PubMed ID: 1104205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Corticosteroid therapy of disseminated sclerosis].
    Lobzin VS; Bardasarova IA; Golovkin VI
    Sov Med; 1985; (9):105-9. PubMed ID: 3906928
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution on intrathecal corticoid therapy (Compiled report of 144 cases)].
    Wilbrandt D
    Z Arztl Fortbild (Jena); 1967 May; 61(10):518-21. PubMed ID: 4386393
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lumbar intrathecal injection of methylprednisolone acetate in the treatment of multiple sclerosis].
    Delzanno GB; Jann G
    Clin Ter; 1969 Jan; 48(2):151-5. PubMed ID: 5409031
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.
    Mazzarello P; Poloni M; Piccolo G; Cosi V; Pinelli P
    Acta Neurol Belg; 1983; 83(4):190-6. PubMed ID: 6689244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone].
    Iarosh AA; Tiazhkorob AM; Prokopiv MM; Kanevskaia SA; Zhovnir IK
    Vrach Delo; 1991 Dec; (12):61-3. PubMed ID: 1792777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylprednisolone acetate in intrathecal administration in multiple sclerosis].
    Palchetti R; Giunta A; Tortoli V; Scarpelli PT
    Rass Neurol Veg; 1965 Jun; 19(3):243-8. PubMed ID: 5899668
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].
    Sbarbaro V; Girelli Bruni E; Monaco V; Gasperini GF; Zardini GB; Brogi L
    Minerva Med; 1974 Sep; 65(65):3407-11. PubMed ID: 4479023
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of vincanine hydrochloride in neurologic practice].
    Shamansurov ShSh; Sultanov MB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(12):1807-9. PubMed ID: 5601840
    [No Abstract]   [Full Text] [Related]  

  • 19. [Considerations on intrathecal administration of corticosteroids in case of multiple sclerosis].
    Cendrowski W
    Wiad Lek; 1976 Feb; 29(3):193-6. PubMed ID: 946336
    [No Abstract]   [Full Text] [Related]  

  • 20. Polarizing solutions and intrathecal methylprednisolone acetate in therapy of multiple sclerosis: preliminary study.
    De Vito SJ; Mannarelli AA
    J Am Osteopath Assoc; 1966 Mar; 65(7):713-22. PubMed ID: 5175985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.